Introduction {#s1}
============

Preferences for prophylactic HPV vaccines have been studied from the perspective of parents [@pone.0097119-Alexander1]--[@pone.0097119-Watts1], health care providers [@pone.0097119-Riedesel1], [@pone.0097119-Daley1], and the individual adolescent/college aged female [@pone.0097119-Hilton1]--[@pone.0097119-Licht1] and male [@pone.0097119-Gerend1], [@pone.0097119-Reiter1]. These works illuminate attitudes and reasons for accepting or rejecting HPV vaccination. The most powerful motivator for young adult behavior, though, is one that is peer-induced [@pone.0097119-Richmond1]--[@pone.0097119-Leigh1] or from within a social network [@pone.0097119-Rice1], [@pone.0097119-Ali1]. No formal work to date has elicited female preferences for male partner vaccination in the context of HPV vaccination. This pairing is unique in that only one vaccine is approved for use in males, and that vaccine has considerably more evidence for genital wart efficacy than anal intraepithelial neoplasia grade 3 (AIN 3) or cancer efficacy for the male population [@pone.0097119-Harper1]. For women, while there are two approved HPV vaccines, practice patterns in countries tend to be skewed towards offering only one, whether due to direct-to-consumer advertising or due to national tenders. In the United States, HPV4 has the majority market share for female vaccination. Understanding women\'s preferences for male partner HPV status has not been explored.

The primary aim of this study was to determine the preference rankings women have about HPV vaccination for a male sexual partner and how these vary by her reproductive health experiences.

Methods {#s2}
=======

This prospective study was approved by the University of Missouri Kansas City (UMKC) Social Sciences Adult Institutional Review Board (SSIRB) (\#SS10-56X) as an exempt study not requiring verbal or written consent and is part of a 601 person study on how women decide to accept or reject the HPV vaccination [@pone.0097119-Harper2].

All women under 27 years old presenting for care at the UMKC Student Health and Wellness office between January 2011 and August 2012 were invited at the time of check-in to participate in this cervical cancer prevention educational intervention. This time frame allowed for 5 academic terms to be surveyed providing the opportunity to reach as many female students as possible, including those who may have taken time away.

Cervical cancer prevention information was written at the seventh grade reading level, as required by the SSIRB. It addressed the three methods of prevention in this age group: Pap testing, each of the two prophylactic HPV vaccines and the combination of Pap testing and HPV vaccination. The strengths and limitations of the three methods were outlined including colposcopy and treatment of detected abnormalities, the HPV genotypes directly covered by each vaccine as well as those prevented by cross-protection, the efficacy of less than three doses, and current evidence for duration of vaccine efficacy. Genital wart coverage was included. Subjects self-reported demographic and past medical history information.

The HPV vaccine preference survey used a 5 point Likert scale (1 = strongly disagree to 5 = strongly agree) to elicit women\'s preferences for her male sexual partner. Partner preference choices were presented as "I want my sexual partner to be vaccinated with Gardasil to prevent spreading warts to me" vs. "I don\'t care if my sexual partner is vaccinated". If she did not have a male partner, her survey was censored. We did not query preferences for concurrent male partners. No identifying information was collected.

Statistics {#s2a}
----------

Frequencies, Chi-square and Fisher\'s exact test were used to show nonrandom associations between two categorical variables with a p\<0.05 considered significant. Mann Whitney U testing was used to compare median preference rankings; Students\' t-test was used for simplifying reporting. Statistica version 12 was used for the analysis [@pone.0097119-StatSoft1]. Data pertaining to cervical cancer screening experiences were limited to those age eligible women 21 years and older.

Results {#s3}
=======

Over the five academic terms from January, 2011 through August 2012, 601 women under the age of 27 years agreed to participate in the cervical cancer prevention educational intervention. The average age of the participating woman was 21.5 years (SD 2.4), of whom 62% were white, 18% black, 4% Hispanic, 9% Asian and 7% of other races/ethnicities ([Table 1](#pone-0097119-t001){ref-type="table"}). Over 90% had not been pregnant nor had a child. The median age at first intercourse was 17 years old, and the median number of sexual partners was 3. Sexual preferences were 94% heterosexual. Condoms and oral contraceptives were used either currently or ever in over half of the population. Of the age-eligible women 21 years and older, 85% had a Pap test in the past, 24% had an abnormal Pap and 15% had been to colposcopy; 12% knew they had had an HPV infection.

10.1371/journal.pone.0097119.t001

###### Demographics of Student Population.
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                                                                            N = 601   mean (SD)
  ------------------------------------------------------------------------ --------- ------------
  **Age, years**                                                              590     21.5 (2.4)
  **Race**                                                                   **n**      **%**
  White                                                                       378        62.3
  Black                                                                       110        18.2
  Hispanic                                                                    24         4.0
  Asian                                                                       53         8.7
  Other                                                                       41         6.8
  **Gravidity**                                                                      
  n = 0                                                                       506        90.2
  n≥1                                                                         55         9.8
  **Parity**                                                                         
  n = 0                                                                       540        96.4
  n≥1                                                                         20         3.6
  **Educational Level**                                                              
  Undergraduate                                                               393        66.7
  Graduate                                                                    111        18.8
  Professional (MD, JD)                                                       85         13.8
  BA/MS Program                                                                4         0.7
  **Income**                                                                         
  \<\$10,000                                                                  212        37.1
  \$10,000--\$30,000                                                          168        29.4
  \$30,000--\$60,000                                                          93         16.3
  \>\$60,000                                                                  98         17.2
  **Age at First Intercourse, years**                                                
  \<14 years                                                                  11         2.2
  14--15 years                                                                74         15.2
  16--17 years                                                                200        41.2
  18--20 years                                                                171        35.2
  \>20 years                                                                  30         6.2
  **Number of Lifetime sexual partners**                                             
  0                                                                           65         12.0
  1--2                                                                        204        37.5
  3--5                                                                        159        29.2
  6--10                                                                       80         14.7
  \>10                                                                        36         6.6
  **Current Relationship Status**                                                    
  Single                                                                      503        85.0
  Married                                                                     39         6.6
  Divorced/Widowed                                                             5         0.8
  Partnered                                                                   45         7.6
  **Contraceptive Use**                                                              
  Current/Ever                                                                311        52.8
  Never                                                                       278        47.2
  **Condom Use**                                                                     
  Yes                                                                         347        61.0
  No                                                                          216        38.0
  Sometimes                                                                    6         1.0
  **History of Pap Screening** [a](#nt101){ref-type="table-fn"}                      
  Yes                                                                         303        85.4
  No                                                                          52         14.6
  **History of Abnormal Pap Screening** [a](#nt101){ref-type="table-fn"}             
  Yes                                                                         86         24.1
  No                                                                          271        75.9
  **History of HPV Infection** [a](#nt101){ref-type="table-fn"}                      
  Yes                                                                         41         11.5
  No                                                                          316        88.5
  **History of Colposcopy** [a](#nt101){ref-type="table-fn"}                         
  Yes                                                                         52         14.6
  No                                                                          305        85.4
  **History of Genital Warts**                                                       
  Yes                                                                         15         2.6
  No                                                                          574        97.4
  **History of STI other than HPV**                                                  
  Yes                                                                         62         10.5
  No                                                                          528        89.5
  **Sexual Preferences**                                                             
  Only Men                                                                    544        94.4
  Only Women                                                                  12         2.1
  Men and Women                                                               20         3.5

among women 21 years and older.

Overall, women had significantly higher preferences for a male partner who was vaccinated than not (median 4 (95% CI: 3--5) vs. 2 (1--3); mean rank 3.9 (SD 1.1) vs. 2.4 (1.1), p\<0.001). [Table 2](#pone-0097119-t002){ref-type="table"} shows that about a quarter of women, regardless of her vaccination status, were neutral in their preference ranking for male partner HPV vaccination. Women not already vaccinated and choosing HPV2 had a significantly lower proportion of high rankings (agree/strongly agree, Likert score of 4/5) for male partner vaccination than women who had at least one dose of prior HPV4 vaccination (67% vs. 75%, p = 0.049); while at the same time having a greater proportion of high rankings for not caring if the male partner was vaccinated (22% vs. 13%, p = 0.015).

10.1371/journal.pone.0097119.t002

###### Women\'s preference rankings for her male partner\'s vaccination status.
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                                                      Strongly disagree/disagree   Neutral   Strongly agree/agree                                                                   
  -------------------------------------------------- ---------------------------- --------- ---------------------- ---- ------- ---- ----- ---------------------------------------- --------------
  Not vaccinated and would choose HPV2 for herself                                                                                                                                  
  Male sexual partner vaccinated with HPV4                        15                8.4%         **\<0.0001**       44   24.7%   NS   119   66.9%[\*](#nt102){ref-type="table-fn"}   **\<0.0001**
  Don\'t care if male partner is vaccinated                       86                49.4%                           50   28.7%        38    21.9%[†](#nt103){ref-type="table-fn"}   
  Not vaccinated and would choose HPV4 for herself                                                                                                                                  
  Male sexual partner vaccinated with HPV4                        3                 3.3%         **\<0.0001**       21   22.8%   NS   68                    73.9%                    **\<0.0001**
  Don\'t care if male partner is vaccinated                       53                57.6%                           27   29.3%        12                    13.1%                   
  Already vaccinated                                                                                                                                                                
  Male sexual partner vaccinated with HPV4                        23                8.3%         **\<0.0001**       45   16.3%   NS   208   75.4%[\*](#nt102){ref-type="table-fn"}   **\<0.0001**
  Don\'t care if male partner is vaccinated                      176                64.0%                           63   22.9%        36    13.1%[†](#nt103){ref-type="table-fn"}   

\*Women not already vaccinated and choosing HPV2 had a significantly lower proportion of strongly agree/agree rankings regarding having her male partner be vaccinated with HPV4 than do vaccinated women (70% vs. 75%, p = 0.049).

Women not already vaccinated and choosing HPV2 had a significantly higher proportion of strongly agree/agree rankings regarding having her male partner be vaccinated with HPV4 than do vaccinated women (22% vs. 13%, p = 0.015).

[Table 3](#pone-0097119-t003){ref-type="table"} extends the preference rankings for male partner vaccination among those women with at least one dose of prior HPV4 vaccination and those women choosing HPV2 vaccination by race, income, and sexual behaviors. In general, the same pattern of significance is seen with greater proportions of women highly ranking male partner vaccination compared to not caring whether the male partner was vaccinated for demographic and sexual behavior characteristics. White women are the only racial group to show a significant difference in proportion of high rankings for 'not caring' whether the male partner is vaccinated: white women choosing HPV2 had a significantly greater proportion of high rankings than did the white women who received at least one dose of HPV4 (28% vs. 14%, p = 0.003). Similarly for women with more than two lifetime sexual partners, a greater proportion of women choosing HPV2 vaccination compared to having received at least one dose of HPV4 vaccine had high rankings for 'not caring' whether the male partner was vaccinated (32% vs. 15%, p = 0.008).

10.1371/journal.pone.0097119.t003

###### Women\'s preference rankings for her male partner\'s HPV vaccination status by her demographic characteristics.

![](pone.0097119.t003){#pone-0097119-t003-3}

                                                                                Not vaccinated and choosing HPV2 for herself            Vaccinated with HPV4                                                                        
  ---------------------------------------------------------------------------- ---------------------------------------------- ---------------------------------------- --------- --------- ---------------------------------------- ---------
  White                                                                                                                                                                                                                             
  Male sexual partner vaccinated with HPV4                                                         61/105                                      58.1%                    \<0.001   140/190                   73.7%                    \<0.001
  Don\'t care if male partner is vaccinated[\*](#nt104){ref-type="table-fn"}                       29/104                      27.9%[\*](#nt104){ref-type="table-fn"}             26/191    13.6%[\*](#nt104){ref-type="table-fn"}  
  Black                                                                                                                                                                                                                             
  Male sexual partner vaccinated with HPV4                                                         31/34                                       91.2%                    \<0.001    36/43                    83.7%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         3/32                                        9.4%                               3/41                      7.3%                   
  Hispanic                                                                                                                                                                                                                          
  Male sexual partner vaccinated with HPV4                                                          4/7                                        57.1%                     0.035     6/10                     60.0%                     0.029
  Don\'t care if male partner is vaccinated                                                         0/7                                          0%                                1/10                     10.0%                   
  Asian                                                                                                                                                                                                                             
  Male sexual partner vaccinated with HPV4                                                         16/22                                       72.7%                    \<0.001    11/16                    68.8%                     0.003
  Don\'t care if male partner is vaccinated                                                         3/21                                       14.3%                               3/17                     17.6%                   
  Income \< \$10,000/year                                                                                                                                                                                                           
  Male sexual partner vaccinated with HPV4                                                         49/67                                       73.1%                    \<0.001   75/104                    72.1%                    \<0.001
  Don\'t care if male partner is vaccinated                                                        16/64                                       25.0%                              15/104                    14.4%                   
  Age at First Intercourse ≤15 years                                                                                                                                                                                                
  Male sexual partner vaccinated with HPV4                                                         11/15                                       73.3%                     0.030     33/46                    71.7%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         4/15                                       26.7%                               5/46                     10.9%                   
  Lifetime Number of Sexual Partners \>2                                                                                                                                                                                            
  Male sexual partner vaccinated with HPV4                                                         41/62                                       66.1%                    \<0.001   108/142                   76.1%                    \<0.001
  Don\'t care if male partner is vaccinated[†](#nt105){ref-type="table-fn"}                        19/60                       31.7%[†](#nt105){ref-type="table-fn"}              22/143    15.4%[†](#nt105){ref-type="table-fn"}   

\*White women not already vaccinated and choosing HPV2 for herself had a significantly higher proportion of strongly agree/agree rankings regarding not caring if her male partner is vaccinated with HPV4 than do white vaccinated women (28% vs. 14%, p = 0.003).

Women not already vaccinated and choosing HPV2 had a significantly higher proportion of strongly agree/agree rankings regarding not caring if her male partner is vaccinated with HPV4 than do vaccinated women when lifetime number of sexual partners exceeds 2 (32% vs. 15%, p = 0.008).

The preference for male vaccination had significantly higher preference rankings than not caring if the male is vaccinated by women who are condom and oral contraceptive users, as well as women with a history of an abnormal Pap test, HPV infection, colposcopy, or other STI\'s ([Table 4](#pone-0097119-t004){ref-type="table"}). Few study participants had genital warts. As seen in [Table 3](#pone-0097119-t003){ref-type="table"}, those women choosing HPV2 vaccine had a greater proportion of high preference rankings for not caring if the male is vaccinated compared to women having received at least one dose of HPV4 (31% vs. 17%, p = 0.007).

10.1371/journal.pone.0097119.t004

###### Women\'s preference rankings for her male partner\'s vaccination status by her reproductive medical history.

![](pone.0097119.t004){#pone-0097119-t004-4}

                                                                                Not vaccinated and choosing HPV2 for herself            Vaccinated with HPV4                                                                        
  ---------------------------------------------------------------------------- ---------------------------------------------- ---------------------------------------- --------- --------- ---------------------------------------- ---------
  Condom Use (Currently/Ever)                                                                                                                                                                                                       
  Male sexual partner vaccinated with HPV4                                                         67/89                                       75.3%                    \<0.001   134/175                   76.6%                    \<0.001
  Don\'t care if male partner is vaccinated                                                        17/87                                       19.5%                              21/174                    12.1%                   
  Oral Contraceptive Use (Currently/Ever)                                                                                                                                                                                           
  Male sexual partner vaccinated with HPV4                                                         44/71                                       62.0%                    \<0.001   105/136                   77.2%                    \<0.001
  Don\'t care if male partner is vaccinated[\*](#nt106){ref-type="table-fn"}                       22/70                       31.4%[\*](#nt106){ref-type="table-fn"}             23/138    16.7%[\*](#nt106){ref-type="table-fn"}  
  History of having had an abnormal Pap test                                                                                                                                                                                        
  Male sexual partner vaccinated with HPV4                                                         19/28                                       76.0%                    \<0.001    42/52                    80.8%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         3/23                                       12.0%                               1/52                      1.9%                   
  History of HPV infection                                                                                                                                                                                                          
  Male sexual partner vaccinated with HPV4                                                          6/8                                        75.0%                     0.004     27/31                    87.1%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         0/8                                         0.0%                               0/31                      0.0%                   
  History of Colposcopy                                                                                                                                                                                                             
  Male sexual partner vaccinated with HPV4                                                         10/17                                       58.8%                     0.004     28/30                    93.3%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         2/17                                       11.8%                               1/30                      3.3%                   
  History of Other STIs                                                                                                                                                                                                             
  Male sexual partner vaccinated with HPV4                                                          9/9                                        100.0%                   \<0.001    29/36                    80.6%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         0/9                                         0.0%                               2/36                      5.4%                   
  History of Genital Warts                                                                                                                                                                                                          
  Male sexual partner vaccinated with HPV4                                                          1/3                                        33.0%                      NS       8/10                     80.0%                    \<0.001
  Don\'t care if male partner is vaccinated                                                         0/3                                         0.0%                               0/10                      0.0%                   

\*Women not already vaccinated and choosing HPV2 for herself had a significantly higher proportion of high rankings regarding not caring if her male partner is vaccinated with HPV4 than do vaccinated women (31% vs. 17%, p = 0.007).

Discussion {#s4}
==========

This work shows that women prefer their male partners to be vaccinated regardless of their choice of vaccine for themselves. This preference is pronounced when the woman has one or more perceived vulnerabilities, e.g. high number of lifetime sexual partners, a past history of HPV infection, abnormal Pap testing, colposcopy or another STI. No other study has reported on women\'s preferences for male HPV vaccination. One study has reported male preferences for cervical cancer screening every 3 years among female family members without any additional preference for HPV vaccination [@pone.0097119-Oteng1].

The cost-effectiveness models show that male HPV vaccination is only cost effective when several conditions are met. These include receiving all three doses on time, assuming lifetime duration of efficacy, vaccination occurs prior to HPV infection and vaccination coverage in the population of potential partnering females is less than 50% [@pone.0097119-Canfell1]--[@pone.0097119-Brisson1]. In addition, the more heterogeneous the sexual contact network of males and females, the less impact male vaccination has on reducing the population prevalence of HPV infection [@pone.0097119-Bogaards1]. While this evidence dissuades male vaccination from a public health viewpoint, a recent mathematical model indicates that vaccinating females with HPV2 and males with HPV4 may maximize the prevention of invasive cervical cancer [@pone.0097119-Drolet1]. Our study has shown that a woman choosing HPV2 for herself expresses less value in having male partner vaccination than does a woman who has received at least one dose of HPV4. Reasons for this decreased value are speculative but may be related to the information provided that shows that 93% of CIN 3 from any HPV type are prevented by HPV2 vs. 43% by HPV4 [@pone.0097119-Heitmann1] and this difference in protection was perceived to be significant enough that she was not as needy for male vaccination.

Other male HPV vaccination studies have focused on parental views about vaccinating sons, male attitudes about vaccine receipt, with some focus on men as male partners, and the provider recommendation for male HPV vaccination [@pone.0097119-Zimet1], all of which offer attitudinal support for male vaccination. The data show that few men (8.3%) have actually acted on this attitude [@pone.0097119-Dorell1] and fewer than 3% have completed the three dose series of HPV4 on time [@pone.0097119-ShenGunther1]. This study may offer influence within the social networking sphere for males to consider receiving HPV4 at the encouragement of their female friends.

Limitations {#s4a}
-----------

This study was conducted on an urban US Midwest college campus among women 18--26 years of age, and as such may not be representative of the perspectives of young adolescent girls or their parents. We did not require the women who had been vaccinated to specify how many doses of vaccine they received.

We did not offer women the choice of no vaccination for herself and vaccination for her male partner; hence we do not know what proportion of women would choose to shift the burden of HPV infection prevention to the male partner. Likewise, we did not ask women their last menstrual period date or cycle regularity, as some sexual preferences for male behavior are linked to the reproductive cycle [@pone.0097119-Gangestad1]. Nor did we ask about male partner concurrency. Furthermore, the preferences elicited here are based on intent and may not necessarily be realized.

Conclusions {#s5}
===========

Women rank highly their preferences for male HPV vaccination. These choices are intensified if the woman has received at least one dose of HPV4 herself.

Renee Krouse, Dawne Buck, Maria Lopez, Deanna Ketner, Glory Ross, Hollie McKinney for help with survey instruction, distribution and collection.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: NMA JCC MSS MAH SMH DMH. Performed the experiments: NMA JCC MXS MAH SMH DAA. Analyzed the data: NMA JCC MSS MAH SMH DMH DAA. Contributed reagents/materials/analysis tools: NMA JCC MSS MAH SMH DMH DAA. Wrote the paper: NMA DMH. Revised the manuscript critically for important intellectual content: NMA JCC MSS MAH SMH DMH DAA. Final approval of the manuscript as submitted: NMA JCC MSS MAH SMH DMH DAA.
